Medicamen Biotech Limited (BOM:531146)
India · Delayed Price · Currency is INR 286.45
-10.50 (-3.54%)
At close: Oct 16, 2026
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.89 billion as of October 16, 2026. It is the 31,407th most valuable company in the world and the 2,158th biggest in India. Its market cap has decreased by 5.05% in one year.
Market Cap
3.89B
Enterprise Value
4.05B
Revenue
2.06B
Global Rank
Country Rank
#2,158 India
PE Ratio
38.45
ChartMarket Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.89B, an increase of 3,481.08%. That is a compound annual growth rate of 17.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 3.89B | -15.84% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wanbury | 6.69B |
| Trident Lifeline | 4.80B |
| Albert David | 4.59B |
| Jenburkt Pharmaceuticals | 4.04B |
| Astonea Labs | 3.41B |
| Ambalal Sarabhai Enterprises | 2.98B |
| BDH Industries | 2.64B |
| Bilcare | 2.33B |